U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services, Equipment), By Facility Type (Independent Labs, Hospital-based Labs), And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 5 Business Days
U.S. Cath Labs Market Growth & Trends
The U.S. cath labs market size is estimated to reach USD 21.9 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.34% from 2023 to 2030. The high incidence of heart disease in the U.S., the improving spending capacity of the residents, the growing number of therapeutic surgeries, and technological advancements are fueling market growth. In addition, the increasing preference for minimally invasive surgeries is expected to offer growth opportunities for the market.
The volume of heart disease diagnostics and surgeries performed is increasing in the U.S. As per the American Heart Association, more than 1 million catheterization surgeries are performed every year. The northeastern and southeastern regions in the U.S. have the highest hospitalization rates for heart disease patients. Michigan, Ohio, West Virginia, Alabama, Georgia, North Carolina, and Kentucky are the states having the highest hospitalization rates for heart disease as per the CDC. This indicates the high requirement for heart disease treatment and the huge accessibility to service in the U.S.
The COVID-19 pandemic resulted in a decline in the number of cardiac procedures as COVID-19 care was the primary focus wherein several cath labs were converted into intensive care units for COVID-19 patients temporarily. The cath labs also witnessed a shortage of medical devices due to disruption in the supply chain during the initial phase of the pandemic. Automated external defibrillators having application in cardiac diagnostic procedures were the equipment having the least supply during the pandemic. The later phase of the pandemic witnessed increased demand for services owing to the rise in heart disease resulting from inactivity during the pandemic.
U.S. Cath Labs Market Report Highlights
U.S. Cath Labs Market Growth & Trends
The U.S. cath labs market size is estimated to reach USD 21.9 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.34% from 2023 to 2030. The high incidence of heart disease in the U.S., the improving spending capacity of the residents, the growing number of therapeutic surgeries, and technological advancements are fueling market growth. In addition, the increasing preference for minimally invasive surgeries is expected to offer growth opportunities for the market.
The volume of heart disease diagnostics and surgeries performed is increasing in the U.S. As per the American Heart Association, more than 1 million catheterization surgeries are performed every year. The northeastern and southeastern regions in the U.S. have the highest hospitalization rates for heart disease patients. Michigan, Ohio, West Virginia, Alabama, Georgia, North Carolina, and Kentucky are the states having the highest hospitalization rates for heart disease as per the CDC. This indicates the high requirement for heart disease treatment and the huge accessibility to service in the U.S.
The COVID-19 pandemic resulted in a decline in the number of cardiac procedures as COVID-19 care was the primary focus wherein several cath labs were converted into intensive care units for COVID-19 patients temporarily. The cath labs also witnessed a shortage of medical devices due to disruption in the supply chain during the initial phase of the pandemic. Automated external defibrillators having application in cardiac diagnostic procedures were the equipment having the least supply during the pandemic. The later phase of the pandemic witnessed increased demand for services owing to the rise in heart disease resulting from inactivity during the pandemic.
U.S. Cath Labs Market Report Highlights
- Based on the component, the service segment held the largest share in 2022. This can be attributed to the increasing prevalence of cardiac diseases
- The diagnostic services are expected to witness higher demand as the federal government focuses on early diagnostics for preventing deaths due to heart disease by imitating awareness campaigns
- In the diagnostic services segment, cardiac catheterization accounted for the largest share in 2022. This can be attributed to the growing prevalence of heart attacks resulting from arterial blockages due to sedimentary lifestyle
- Based on facility type, hospital-based facilities dominated the market in 2022 owing to the increasing number of chronic and emergency cases and improved reimbursement for hospital-based labs. Hospitals are modernizing their existing cath labs and investing in hybrid laboratory integration to treat multiple conditions under one roof and increase profitability
- The 2022 reimbursement policy by the CMS focuses on a value-based program paying the service providers based on patient outcomes rather than quantity. This is resulting in enhancing the quality of patient care
- Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For instance, in September 2022, Medtronic acquired a cardiac mapping company Affera, aiding the company’s diagnostic portfolio
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2 Competitive Landscape
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rising incidence of cardiovascular disease
3.3.1.2 Low operational cost
3.3.1.3 Technological advancement
3.3.2 Market restraint analysis
3.3.2.1 Lack of reimbursement for independent lab
3.3.2.2 High maintenance cost for multispecialty labs
3.4 U.S. Cath Labs Industry Analysis - Porter’s
3.4.1 Bargaining power of buyers
3.4.2 Bargaining power of suppliers
3.4.3 Competitive rivalry
3.4.4 Threat of new entrants
3.4.5 Threat of substitutes
3.5 Regulatory & Reimbursement Scenario
3.6 Qualitative Analysis: Impact of COVID-19 on U.S. Cath Labs Market
CHAPTER 4 U.S. CATH LABS MARKET: COMPONENT ANALYSIS
4.1 U.S. Cath Labs Component Market Share Analysis, 2022&2030
4.2 U.S. Cath Labs ComponentMarket: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, Component Segment, 2017 to 2030
4.3.1 Services
4.3.1.1 Services Market, 2017 - 2030 (USD Million)
4.3.1.2 Therapeutic services
4.3.1.2.1 Therapeutic services market, 2017 - 2030 (USD Million)
4.3.1.2.2 Angioplasty
4.3.1.2.2.1 Angioplasty market, 2017 - 2030 (USD Million)
4.3.1.2.3 Stent Placement
4.3.1.2.3.1 Stent Placement market, 2017 - 2030 (USD Million)
4.3.1.2.4 Rotational atherectomy
4.3.1.2.4.1 Rotational atherectomy market, 2017 - 2030 (USD Million)
4.3.1.2.5 Thrombectomy
4.3.1.2.5.1 Thrombectomy market, 2017 - 2030 (USD Million)
4.3.1.2.6 Cardioversion
4.3.1.2.6.1 Cardioversion market, 2017 - 2030 (USD Million)
4.3.1.2.7 Transcatheter Aortic Valve Replacement (TAVR)
4.3.1.2.7.1 Transcatheter Aortic Valve Replacement (TAVR) market, 2017 - 2030 (USD Million)
4.3.1.2.8 Others
4.3.1.2.8.1 Others market, 2017 - 2030 (USD Million)
4.3.1.3 Diagnostic services
4.3.1.3.1 Diagnostic services market, 2017 - 2030 (USD Million)
4.3.1.3.2 Angiography
4.3.1.3.2.1 Angiography market, 2017 - 2030 (USD Million)
4.3.1.3.3 Coronary intravascular ultrasound
4.3.1.3.3.1 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
4.3.1.3.4 Cardiac catheterization
4.3.1.3.4.1 Cardiac catheterization market, 2017 - 2030 (USD Million)
4.3.1.3.5 ECG/EKG
4.3.1.3.5.1 ECG/EKG market, 2017 - 2030 (USD Million)
4.3.1.3.6 Fractional Flow Reserve (FFR)
4.3.1.3.6.1 Fractional Flow Reserve (FFR) market, 2017 - 2030 (USD Million)
4.3.1.3.7 Others
4.3.1.3.7.1 Others market, 2017 - 2030 (USD Million)
4.3.2 Equipment
4.3.2.1 Equipment, 2017 - 2030 (USD Million)
CHAPTER 5 U.S. CATH LABS MARKET: FACILITYTYPE ANALYSIS
5.1 U.S. Cath LabsFacilityType Market Share Analysis, 2022& 2030
5.2 U.S. Cath Labs FacilityType Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, FacilityType Segment, 2017 to 2030
5.3.1 Independent Labs
5.3.1.1 Independent Labs, 2017 - 2030 (USD Million)
5.3.2 Hospital-based Labs
5.3.2.1 Hospital-based market, 2017 - 2030 (USD Million)
CHAPTER 6 COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Koninklijke Philips N.V.
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Service benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Shimadzu Corporation
6.4.2.1 Company overview
6.4.2.2Financial performance
6.4.2.3 Service benchmarking
6.4.2.4 Strategic initiatives
6.4.3 GE Healthcare
6.4.4.1Company overview
6.4.4.2Financial Performance
6.4.4.3 Service benchmarking
6.4.4.4 Strategic initiatives
6.4.4 Johnson & Johnson
6.4.4.1Company overview
6.4.4.2Financial Performance
6.4.4.3 Service benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Braun Melsungen AG
6.4.5.1 Company overview
6.4.5.2 Financial Performance
6.4.5.2 Service benchmarking
6.4.5.3 Strategic initiatives
6.4.6 Siemens Healthineers
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Service benchmarking
6.4.6.4 Strategic initiatives
6.4.7 Medtronic
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Service benchmarking
6.4.7.4 Strategic initiatives
6.4.8 Cardinal Health, Inc.
6.4.8.1 Company overview
6.4.8.2 Financial performance
6.4.8.3 Service benchmarking
6.4.8.4 Strategic initiatives
6.4.9 Boston Scientific Corporation
6.4.9.1 Company overview
6.4.92 Financial performance
6.4.9.3 Service benchmarking
6.4.9.4 Strategic initiatives
6.4.10 Abbott Laboratories
6.4.10.1 Company overview
6.4.10.2 Financial performance
6.4.10.3 Service benchmarking
6.4.10.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2 Competitive Landscape
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rising incidence of cardiovascular disease
3.3.1.2 Low operational cost
3.3.1.3 Technological advancement
3.3.2 Market restraint analysis
3.3.2.1 Lack of reimbursement for independent lab
3.3.2.2 High maintenance cost for multispecialty labs
3.4 U.S. Cath Labs Industry Analysis - Porter’s
3.4.1 Bargaining power of buyers
3.4.2 Bargaining power of suppliers
3.4.3 Competitive rivalry
3.4.4 Threat of new entrants
3.4.5 Threat of substitutes
3.5 Regulatory & Reimbursement Scenario
3.6 Qualitative Analysis: Impact of COVID-19 on U.S. Cath Labs Market
CHAPTER 4 U.S. CATH LABS MARKET: COMPONENT ANALYSIS
4.1 U.S. Cath Labs Component Market Share Analysis, 2022&2030
4.2 U.S. Cath Labs ComponentMarket: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, Component Segment, 2017 to 2030
4.3.1 Services
4.3.1.1 Services Market, 2017 - 2030 (USD Million)
4.3.1.2 Therapeutic services
4.3.1.2.1 Therapeutic services market, 2017 - 2030 (USD Million)
4.3.1.2.2 Angioplasty
4.3.1.2.2.1 Angioplasty market, 2017 - 2030 (USD Million)
4.3.1.2.3 Stent Placement
4.3.1.2.3.1 Stent Placement market, 2017 - 2030 (USD Million)
4.3.1.2.4 Rotational atherectomy
4.3.1.2.4.1 Rotational atherectomy market, 2017 - 2030 (USD Million)
4.3.1.2.5 Thrombectomy
4.3.1.2.5.1 Thrombectomy market, 2017 - 2030 (USD Million)
4.3.1.2.6 Cardioversion
4.3.1.2.6.1 Cardioversion market, 2017 - 2030 (USD Million)
4.3.1.2.7 Transcatheter Aortic Valve Replacement (TAVR)
4.3.1.2.7.1 Transcatheter Aortic Valve Replacement (TAVR) market, 2017 - 2030 (USD Million)
4.3.1.2.8 Others
4.3.1.2.8.1 Others market, 2017 - 2030 (USD Million)
4.3.1.3 Diagnostic services
4.3.1.3.1 Diagnostic services market, 2017 - 2030 (USD Million)
4.3.1.3.2 Angiography
4.3.1.3.2.1 Angiography market, 2017 - 2030 (USD Million)
4.3.1.3.3 Coronary intravascular ultrasound
4.3.1.3.3.1 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
4.3.1.3.4 Cardiac catheterization
4.3.1.3.4.1 Cardiac catheterization market, 2017 - 2030 (USD Million)
4.3.1.3.5 ECG/EKG
4.3.1.3.5.1 ECG/EKG market, 2017 - 2030 (USD Million)
4.3.1.3.6 Fractional Flow Reserve (FFR)
4.3.1.3.6.1 Fractional Flow Reserve (FFR) market, 2017 - 2030 (USD Million)
4.3.1.3.7 Others
4.3.1.3.7.1 Others market, 2017 - 2030 (USD Million)
4.3.2 Equipment
4.3.2.1 Equipment, 2017 - 2030 (USD Million)
CHAPTER 5 U.S. CATH LABS MARKET: FACILITYTYPE ANALYSIS
5.1 U.S. Cath LabsFacilityType Market Share Analysis, 2022& 2030
5.2 U.S. Cath Labs FacilityType Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, FacilityType Segment, 2017 to 2030
5.3.1 Independent Labs
5.3.1.1 Independent Labs, 2017 - 2030 (USD Million)
5.3.2 Hospital-based Labs
5.3.2.1 Hospital-based market, 2017 - 2030 (USD Million)
CHAPTER 6 COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Koninklijke Philips N.V.
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Service benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Shimadzu Corporation
6.4.2.1 Company overview
6.4.2.2Financial performance
6.4.2.3 Service benchmarking
6.4.2.4 Strategic initiatives
6.4.3 GE Healthcare
6.4.4.1Company overview
6.4.4.2Financial Performance
6.4.4.3 Service benchmarking
6.4.4.4 Strategic initiatives
6.4.4 Johnson & Johnson
6.4.4.1Company overview
6.4.4.2Financial Performance
6.4.4.3 Service benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Braun Melsungen AG
6.4.5.1 Company overview
6.4.5.2 Financial Performance
6.4.5.2 Service benchmarking
6.4.5.3 Strategic initiatives
6.4.6 Siemens Healthineers
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Service benchmarking
6.4.6.4 Strategic initiatives
6.4.7 Medtronic
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Service benchmarking
6.4.7.4 Strategic initiatives
6.4.8 Cardinal Health, Inc.
6.4.8.1 Company overview
6.4.8.2 Financial performance
6.4.8.3 Service benchmarking
6.4.8.4 Strategic initiatives
6.4.9 Boston Scientific Corporation
6.4.9.1 Company overview
6.4.92 Financial performance
6.4.9.3 Service benchmarking
6.4.9.4 Strategic initiatives
6.4.10 Abbott Laboratories
6.4.10.1 Company overview
6.4.10.2 Financial performance
6.4.10.3 Service benchmarking
6.4.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S.cath labsmarketestimates and forecast, by component, 2017 - 2030 (USD Million)
Table 4 U.S.cath labs market estimates and forecast, by facility type 2017 - 2030 (USD Million)
Table 5 U.S.cath labs services market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 6 U.S.cath labs therapeuticservices market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 7 U.S.cath labs diagnosticservices market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S.cath labsmarketestimates and forecast, by component, 2017 - 2030 (USD Million)
Table 4 U.S.cath labs market estimates and forecast, by facility type 2017 - 2030 (USD Million)
Table 5 U.S.cath labs services market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 6 U.S.cath labs therapeuticservices market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 7 U.S.cath labs diagnosticservices market estimates and forecast, by type 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Cath labs market segmentation
Fig. 9 Market outlook, 2022 (USD Million)
Fig. 10 U.S. Cath labs market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 U.S. Cath labs component market share analysis, (USD Million)
Fig. 15 U.S Cath labs component market: Segment dashboard
Fig. 16 Services market, 2017 - 2030 (USD Million)
Fig. 18 Therapeutic services market, 2017 - 2030 (USD Million)
Fig. 19 Angioplasty market, 2017 - 2030 (USD Million)
Fig. 20 Stent placement market, 2017 - 2030 (USD Million)
Fig. 21 Rotational atherectomy market, 2017 - 2030 (USD Million)
Fig. 22 Thrombectomy market, 2017 - 2030 (USD Million)
Fig. 23 Cardioversion market, 2017 - 2030 (USD Million)
Fig. 24 TAVR market, 2017 - 2030 (USD Million)
Fig. 25 Others market, 2017 - 2030 (USD Million)
Fig. 26 Diagnostic services market, 2017 - 2030 (USD Million)
Fig. 27 Angiography market, 2017 - 2030 (USD Million)
Fig. 28 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
Fig. 29 Cardiac catheterization atherectomy market, 2017 - 2030 (USD Million)
Fig. 30 ECG/EKG market, 2017 - 2030 (USD Million)
Fig. 31 Fractional flow reserve market, 2017 - 2030 (USD Million)
Fig. 32 Others market, 2017 - 2030 (USD Million)
Fig. 33 Equipment market, 2017 - 2030 (USD Million)
Fig. 34 U.S. Cath labs facility type market share analysis, (USD Million)
Fig. 35 U.S Cath labs facility type market: Segment dashboard
Fig. 36 Independent labs market, 2017 - 2030 (USD Million)
Fig. 37 Hospital-based labs market, 2017 - 2030 (USD Million)
Fig. 38 Impact analysis by key market participants
Fig. 39Competition categorization
Fig. 40 Company market position analysis
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Cath labs market segmentation
Fig. 9 Market outlook, 2022 (USD Million)
Fig. 10 U.S. Cath labs market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 U.S. Cath labs component market share analysis, (USD Million)
Fig. 15 U.S Cath labs component market: Segment dashboard
Fig. 16 Services market, 2017 - 2030 (USD Million)
Fig. 18 Therapeutic services market, 2017 - 2030 (USD Million)
Fig. 19 Angioplasty market, 2017 - 2030 (USD Million)
Fig. 20 Stent placement market, 2017 - 2030 (USD Million)
Fig. 21 Rotational atherectomy market, 2017 - 2030 (USD Million)
Fig. 22 Thrombectomy market, 2017 - 2030 (USD Million)
Fig. 23 Cardioversion market, 2017 - 2030 (USD Million)
Fig. 24 TAVR market, 2017 - 2030 (USD Million)
Fig. 25 Others market, 2017 - 2030 (USD Million)
Fig. 26 Diagnostic services market, 2017 - 2030 (USD Million)
Fig. 27 Angiography market, 2017 - 2030 (USD Million)
Fig. 28 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
Fig. 29 Cardiac catheterization atherectomy market, 2017 - 2030 (USD Million)
Fig. 30 ECG/EKG market, 2017 - 2030 (USD Million)
Fig. 31 Fractional flow reserve market, 2017 - 2030 (USD Million)
Fig. 32 Others market, 2017 - 2030 (USD Million)
Fig. 33 Equipment market, 2017 - 2030 (USD Million)
Fig. 34 U.S. Cath labs facility type market share analysis, (USD Million)
Fig. 35 U.S Cath labs facility type market: Segment dashboard
Fig. 36 Independent labs market, 2017 - 2030 (USD Million)
Fig. 37 Hospital-based labs market, 2017 - 2030 (USD Million)
Fig. 38 Impact analysis by key market participants
Fig. 39Competition categorization
Fig. 40 Company market position analysis
